3D analysis is superior to 2D analysis for contrast-enhanced ultrasound in revealing vascularity in focal liver lesions – A retrospective analysis of 83 cases

Dong, Fajin; Xu, Jinfeng; Du, Dong; Jiao, Yang; Zhang, Lei; Li, Min; Liu, Huiyu; Xiong, Yi; Luo, Hao

doi:10.1016/j.ultras.2016.05.007

Cited by 20 publications

(17 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Practitioners need to be competent in the intravenous administration of contrast agents, be familiar with contraindications and be able to manage any possible adverse effects within the medical and legal framework of their country 4 38 . We refer to the educational activities of the collaborating societies of this paper, the World Federation of Ultrasound in Medicine and Biology (WFUMB) 9 23 93 94 95 96 97 98 99 100 101 102 , the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) 1 3 4 11 37 38 49 50 74 79 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 and the CEUS LI-RADS Working Group for Liver Imaging Reporting and Data System (LI-RADS®) 34 35 36 120 121 122 123 124 .…”

Section: Education Qualificationmentioning

confidence: 99%

How to perform Contrast-Enhanced Ultrasound (CEUS)

Dietrich

Averkiou

Nielsen

et al. 2018

Ultrasound Int Open

285

273

View full text Add to dashboard Cite

“How to perform contrast-enhanced ultrasound (CEUS)” provides general advice on the use of ultrasound contrast agents (UCAs) for clinical decision-making and reviews technical parameters for optimal CEUS performance. CEUS techniques vary between centers, therefore, experts from EFSUMB, WFUMB and from the CEUS LI-RADS working group created a discussion forum to standardize the CEUS examination technique according to published evidence and best personal experience. The goal is to standardise the use and administration of UCAs to facilitate correct diagnoses and ultimately to improve the management and outcomes of patients.

show abstract

Section: Education Qualificationmentioning

confidence: 99%

How to perform Contrast-Enhanced Ultrasound (CEUS)

Dietrich

Averkiou

Nielsen

et al. 2018

Ultrasound Int Open

285

273

View full text Add to dashboard Cite

show abstract

“…The main limitations of our study were the small number of patients considered, the lack of a control ROI in normal liver parenchyma, the fact that we were only able to scan one index liver lesion per patient rather than different liver metastases, and the failure to use 3D-CEUS. Of note, it has recently come to light that dynamic 3D-CEUS is superior to 2D-CEUS in visualizing the spatial relationship, vascularity and perfusion patterns of focal liver lesions [33]. Generally speaking, the use of various methodologies for contrast quantification based on different software programs has led to disparities in trial Fig.…”

Section: Discussionmentioning

confidence: 99%

Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Dynamic 3D-CEUS is superior to 2D-CEUS in displaying the spatial relationship of HCCs and their vascularity patterns and simultaneous imaging of HCC perfusion and anatomic features [ 35 ]. Dynamic 3D-CEUS can be shown in “multislice” displaying mode, which can help display RT alongside the border of the HCC lesions.…”

Section: Discussionmentioning

confidence: 99%

Dynamic Three-Dimensional Contrast-Enhanced Ultrasound to Predict Therapeutic Response of Radiofrequency Ablation in Hepatocellular Carcinoma: Preliminary Findings

Cao

Mao

et al. 2018

BioMed Research International

View full text Add to dashboard Cite

Background & Aims To investigate the value of dynamic three-dimensional contrast-enhanced ultrasound (3D-CEUS) in the assessment of therapeutic response of hepatocellular carcinoma (HCC) treated with radiofrequency ablation (RFA). Methods Forty-two patients (31 men and 11 women; mean age (52.1 ± 13.1 years)) with 42 clinical diagnosed HCC lesions (size range 14-48 mm; mean size 28.4 ± 9.9 mm) treated by RFA were included. All patients underwent two-dimensional contrast-enhanced ultrasound (2D-CEUS) and 3D-CEUS 1 month after treatment. Two radiologists assessed the absence (complete response, CR) or presence (residual tumor, RT) of any arterially hyperenhancing nodules within or along the margin of the treated HCC lesions. Complete response on magnetic resonance (MR) imaging acted as standard of reference (SOR). Results After RFA treatment, 3D-CEUS was successfully conducted in 34 HCC lesions. CR was observed on both 2D-CEUS and 3D-CEUS in 25/42 (59.5%) HCC and RT in 6/42 (14.3%) HCC lesions. In 3/42 (7.1%) HCC lesion, RT was documented by SOR and 3D-CEUS, but it was not appreciable at 2D-CEUS. In 3/42 (7.1%) HCC lesion, the presence of peripheral RT was suspected by both 2D-CEUS and 3D-CEUS, but it was not confirmed by SOR. No statistically significant difference between 2D-CEUS and 3D-CEUS in depicting either CR or RT was found (P = 0.25). Combined with dynamic 3D-CEUS, the diagnostic accuracy was improved from 85.7% to 92.9%. Conclusions 3D-CEUS might be helpful in better diagnostic performance in the assessment of therapeutic response of HCC treated after RFA.

show abstract

3D analysis is superior to 2D analysis for contrast-enhanced ultrasound in revealing vascularity in focal liver lesions – A retrospective analysis of 83 cases

Cited by 20 publications

References 4 publications

How to perform Contrast-Enhanced Ultrasound (CEUS)

How to perform Contrast-Enhanced Ultrasound (CEUS)

Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer

Dynamic Three-Dimensional Contrast-Enhanced Ultrasound to Predict Therapeutic Response of Radiofrequency Ablation in Hepatocellular Carcinoma: Preliminary Findings

Contact Info

Product

Resources

About